• KOL
    • Allergic Conjunctivitis
    • Add/adhd Kols
    • Key People For Allergic Conjunctivitis

      Top KOLs in the world
      #1
      Mark B Abelson
      allergic conjunctivitis dry eye ophthalmic solution
      #2
      Leonard Bielory
      allergic conjunctivitis ocular allergy united states
      #3
      Andrea A Leonardi
      vernal keratoconjunctivitis allergic conjunctivitis ocular allergy
      #4
      Giorgio Walter Canonica
      allergic rhinitis severe asthma sublingual immunotherapy
      #5
      Sergio Bonini
      allergic rhinitis nerve growth factor vernal keratoconjunctivitis
      #6
      Mathea R Allansmith
      vernal conjunctivitis mast cells ocular anaphylaxis

      Role of histamine H4 receptor in allergic conjunctivitis in mice

      Abstract

      We investigated the character of histamine H(1) receptor and H(4) receptor in allergic conjunctivitis. Histamine is the most important mediator in allergic conjunctivitis. We measured eye scratching behavior and allergic-like symptoms score, that is, hyperemia and edema in ICR mice, and examined which receptors intimately involved in allergic conjunctivitis. Histamine caused a dose-dependent eye scratching behavior and allergic-like symptoms. Histamine H(1) receptor antagonist (levocabastine) and H(4) receptor antagonist (JNJ7777120) inhibited eye scratching behavior and histamine H(1) receptor antagonist inhibited allergic-like symptoms induced by histamine. Additionally, combination of levocabastine and JNJ7777120 caused more potent inhibition in allergic conjunctivitis. On the other hand, both selective histamine H(1) receptor agonist (HTMT) and selective H(4) receptor agonist (4-methylhistamine) induced a dose-dependent eye scratching behavior and allergic-like symptoms. JNJ7777120 inhibited the effect of HTMT. However, levocabastine caused no inhibition on the response of 4-methylhistamine. H(4) receptor was closely related with allergic conjunctivitis. H(4) receptor antagonists may be effective in allergic conjunctivitis which showed no inhibition by histamine H(1) receptor antagonists.

      Sign-in to see all concepts, it's free!

       

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.